Canine longevity drug advances toward FDA approvalMarch 4, 2025The FDA’s Center for Veterinary Medicine has accepted the Reasonable Expectation of Effectiveness (RXE) for LOY-002. Learn more about what this ‘milestone’ means in the pursuit of an FDA conditional approval.
SPONSORED CONTENTDon't just protect. Triple protect.One tasty monthly chew. Approved for puppies as young as 8 weeks, weighing at least 2.8 lbs. + Learn more
$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M
